Early Phase 1 HER2-positive Clinical Trials

3 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–3 of 3 trials

Recruiting

Early Phase 1

SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors

HER2-Positive Advanced Solid Tumors

Shanghai Pharmaceuticals Holding Co., Ltd150 enrolled17 locationsNCT05245058

Recruiting

Early Phase 1

Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer

Breast CancerTriple-Negative Breast CancerHER2-positive Breast Cancer+3 more

Alison Stopeck30 enrolled1 locationNCT06220214

Recruiting

Early Phase 1

TGW211 for Click-Cleavable Imaging in HER2-Positive Cancers.

HER2-Positive Solid Tumor

Radboud University Medical Center19 enrolled1 locationNCT07009184